Benserazide + Levodopa
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Benserazide
benserazide - Levodopa
levodopa
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| levodopa + benserazideAU ES | 100 mg / 200 mg / 50 mg / 12.5 mg / 25 mg | Roche Products Pty Ltd |
| Madopar 125AU SG |
| Roche Products Pty Ltd |
| MINT-LEVODOPA/BENSERAZIDECA |
| MINT PHARMACEUTICALS INC |
| LEVODOPA/BENSERAZIDE TEVA 100 mg/25 mg, géluleFR |
| TEVA SANTE |
| levodopa + benserazidaES | 100 mg / 200 mg | Roche Farma S.A. |
| MADOPAR 250 TABLET 250 mgHK SG |
| ROCHE HONG KONG LIMITED |
| MADOPAR 250 levodopa 200 mg and benserazide 50 mg capsule bottleAU |
| Roche Products Pty Ltd |
| MADOPAR 125 levodopa 100 mg and benserazide 25 mg capsule bottleAU |
| Roche Products Pty Ltd |
| MADOPAR 200mg/50ES |
| Roche Farma S.A. |
| Madopar Rapid 62.5AU |
| Roche Products Pty Ltd |
| Madopar 62.5AU |
| Roche Products Pty Ltd |
| Madopar HBSAU |
| Roche Products Pty Ltd |
| Madopar Rapid 125AU |
| Roche Products Pty Ltd |
| levodopa + benserazide hydrochloride + benserazideAU | — | — |
| PROLOPA 100-25CA |
| HOFFMANN-LA ROCHE LIMITED |
| PROLOPA 200-50CA |
| HOFFMANN-LA ROCHE LIMITED |
| PROLOPA 50-12.5CA |
| HOFFMANN-LA ROCHE LIMITED |
| "信東"賓渡帕膠囊125毫克TW |
| 信東生技股份有限公司 |
| BENDOPAR CAPSULES 125MGTW |
| 信東生技股份有限公司 |
| "羅氏"美道普持續性藥效膠囊100/25毫克TW |
| 羅氏大藥廠股份有限公司 |
| MADOPAR HBS CAPSULES 125MG "ROCHE"TW |
| 羅氏大藥廠股份有限公司 |
| "衛達"本得保膠囊TW |
| 衛達化學製藥股份有限公司 |
| BENDOPA CAPSULES "WEIDAR"TW |
| 衛達化學製藥股份有限公司 |
| 美道普錠200/50毫克TW |
| 羅氏大藥廠股份有限公司 |
| MADOPAR 250 TABLETS "ROCHE"TW |
| 羅氏大藥廠股份有限公司 |
| "信東" 賓渡帕膠囊250毫克TW |
| 信東生技股份有限公司 |
| BENDOPAR CAPSULES 250MG "S.T."TW |
| 信東生技股份有限公司 |
| MADOPAR HBS 125 CAPSULESG |
| ROCHE SINGAPORE PTE. LTD. |
| MADOPAR DISP 125 TABHK |
| ROCHE HONG KONG LIMITED |
| MADOPAR HBS CAP "125" CONTROLLED RELEASEHK |
| ROCHE HONG KONG LIMITED |
| MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottleAU |
| Roche Products Pty Ltd |
| MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottleAU |
| Roche Products Pty Ltd |
| MADOPAR RAPID 125 levodopa 100 mg and benserazide 25 mg dispersible tablet bottleAU |
| Roche Products Pty Ltd |
| MADOPAR RAPID 62.5 levodopa 50 mg and benserazide 12.5 mg dispersible tablet bottleAU |
| Roche Products Pty Ltd |
| MODOPAR 125 (100 mg/25 mg), géluleFR |
| ROCHE |
| MODOPAR 125 DISPERSIBLE (100 mg/25 mg), comprimé sécable pour suspension buvableFR |
| ROCHE |
| MODOPAR 250 (200 mg/50 mg), géluleFR |
| ROCHE |
| MODOPAR 62,5 (50 mg/12,5 mg), géluleFR |
| ROCHE |
| MODOPAR L.P. 125 (100 mg/25 mg), gélule à libération prolongéeFR |
| ROCHE |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · MINT-LEVODOPA/BENSERAZIDE; PROLOPA 100-25; PROLOPA 200-50 · 6 products · record
- ES · MADOPAR 200mg/50; MADOPAR · 2 products · record
- AU · Madopar 125; MADOPAR; Madopar Rapid 62.5 · 8 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.